Sinh G, Pandya SK, Dastur DK. Pathogenesis of unusual intracranial tuberculomas and tuberculous space-occupying lesions. J Neurosurg. 1968;29:149-159.
2.
Awada A, Daif AK, Pirani M, et al.Evolution of brain tuberculomas under standard antituberculous treatment. J Neurol Sci. 1998;156:47-52.
3.
Cheng VC, Ho PL, Lee RA, et al.Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803-809.
4.
Orlovic D, Smego RA Jr. Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis. 2001;5:370-375.
5.
Hass DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell: Principles and Practice of Infectious Diseases, 5th ed.Orlando, FL: Churchill Livingstone; 2000:2599.
6.
Garcia de Viedma D, Marin M, Ruiz Serrano MJ, et al.Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis. 2003;187:695-699.
7.
Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med. 1996;184:1737-1745.
8.
Matyszak MK, Perry VH. Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition. J Neuroimmunol. 1998;82:73-80.
9.
Constant P, Perez E, Malaga W, et al.Role of the PKS15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methly esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the PKS15/1 gene. J Biol Chem. 2002;277:38148-38158.
10.
American Thoracic Society/Center for Disease Control and Prevention/Infectious Disease society of America. Treatment of Tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.
